Focusing on the compliance development of pharmaceutical companies - the compliance sharing meeting of pharmaceutical companies to prevent commercial bribery risk was successfully held
On the afternoon of March 21, 2025, the "Compliance Sharing Meeting for Pharmaceutical Enterprises to Prevent Commercial Bribery Risks" co-sponsored by Zhiheng Legal Affairs Center and Criminal Cross Legal Affairs Center was held in the large conference room of
. The meeting focused on the cutting-edge trends of the pharmaceutical industry, in-depth discussion of how pharmaceutical companies can effectively prevent the risk of commercial bribery, using offline participation combined with online live broadcast, attracting many legal professionals and representatives of pharmaceutical companies to participate in the meeting to discuss the development of industry compliance.
Liu Hong, Deputy Director of Zhiheng Headquarters Management Committee and Director of the Company's Legal Affairs Center, Wang Zhenghua, Director of Zhiheng Criminal Cross Legal Affairs Center and Deputy Director of Zhiheng Qianhai Management Committee, Cui Ran, Deputy Director of Corporate Compliance and Anti-Fraud Professional Committee of Zhiheng Criminal Cross Legal Affairs Center and Deputy Secretary-General of Criminal Cross Legal Professional Committee of Shenzhen Lawyers Association, song Cheng, Secretary General of the Medical and Health Branch of Shenzhen Enterprise Compliance Association, member of the Medical Committee of Shenzhen Law Association and senior partner of Zhiheng Qianhai Equity, attended.
Li Ci, Secretary-General of the Corporate Compliance Department of the Legal Affairs Center of Zhiheng Company and member of the Data Compliance Center of the Qianhai Law Working Committee of Shenzhen Law Association, presided over the event.
Guest Speech
liu Hong, Deputy Director of Management Committee of Zhiheng Headquarters and Director of Legal Affairs Center of the Company
deputy Director Liu Hong introduced the operating status of the Legal Affairs Center of Zhiheng Company. He said that the first few days was the first anniversary of the establishment of the center. Over the past year, relying on Zhiheng's brand and talent advantages, the center has deeply studied the company law and relevant laws and regulations, and established a standardized operation mechanism. The center takes "regional management" and "professional subdivision" as the organizational structure, and focuses on the concept of "building a first-class company legal service team", organizes professional seminars in a planned and step-by-step manner, actively writes professional articles, and jointly publishes Monographs, condense team wisdom, intensive professional research, and down-to-earth work to promote common growth and progress.
Deputy Director Liu Hong pointed out that the compliance sharing meeting for pharmaceutical companies to prevent commercial bribery risks held today is one of the purposes of the establishment of the center. Through such activities, the center has strengthened professional construction, shared legal insights, and inspired new ideas.
Theme sharing
cui Ran, Deputy Director of the Corporate Compliance and Anti-Fraud Professional Committee of Zhiheng Criminal and Civil Cross Legal Affairs Center, and Deputy Secretary-General of the Criminal and Civil Cross Legal Professional Committee of Shenzhen Lawyers Association
lawyer Cui Ran interpreted in detail the Compliance Guidelines for Pharmaceutical Enterprises to Prevent Commercial Bribery Risks issued by the General Administration of Market Supervision from four aspects: the background and purpose of the formulation, the construction of a compliance management system for pharmaceutical enterprises to prevent commercial bribery risks, the identification and prevention of commercial bribery risks, and the disposal of commercial bribery risks.
Lawyer Cui Ran pointed out that the scenario-based and hierarchical design of the Guidelines fills the gap in the field of pharmaceutical compliance. Enterprises can combine their own business characteristics, focus on preventing high-risk scenarios, and use the guidelines to provide compliance tools (such as self-test scoring table, document template library) to improve the internal control system.
This not only reduces the occurrence of criminal offences through administrative compliance, but also enhances the rigidity of administrative law enforcement through criminal deterrence, ultimately forming a closed loop of full-chain governance of "prevention in advance-control in the process-linkage after the event.
Song Cheng, Secretary-General of the Medical and Health Branch of Shenzhen Enterprise Compliance Association, Member of the Medical Committee of Shenzhen Law Association and Senior Partner of Zhiheng Qianhai Equity.
Lawyer Song Cheng shared in depth on the theme of "Insight: Summary of Changes in Demand for Legal Services in the Field of Medicine. Lawyer Song Cheng analyzed the latest developments in the pharmaceutical field in detail from four aspects: the core and supply chain of the pharmaceutical field, the changes in the medical field, the impact of the pharmaceutical industry, and the impact of the medical equipment industry.
Combined with these changes, lawyer Song Cheng introduced legal services in the medical field, covering criminal legal services (such as duty crime cases, medical insurance fraud criminal cases), public medical institutions (compliance) (such as compliance of medical institutions, asset digitization, information protection of artificial intelligence) and private medical institutions (expansion) (such as mergers and acquisitions, entry of foreign hospitals), etc, provides valuable legal perspective and professional insights to the industry.
Guest Comments
wang Zhenghua, Director of Zhiheng Criminal Cross Legal Affairs Center and Deputy Director of Zhiheng Qianhai Administrative Committee
lawyer Wang Zhenghua commented on the depth and breadth of the compliance sharing meeting of pharmaceutical enterprises to prevent commercial bribery risks. He pointed out that the reason why the sharing meeting focused on the compliance guidelines of pharmaceutical enterprises is that his team is in the forefront of relevant research, especially paying attention to China, as a pharmaceutical market with about 5000 pharmaceutical enterprises and a large scale, the pharmaceutical industry is not only related to the health of the whole people, but also facing new development patterns such as enterprise upgrading technology and integration of foreign enterprises.
In such a critical period, how to accurately position and provide professional legal services in the vast market, how to help enterprises do a good job in compliance construction, clear red lines and principles, has become an important topic to be discussed.
Lawyer Wang Zhenghua emphasized that he hopes that through this seminar, lawyers and colleagues will have a clearer understanding of the compliance services of pharmaceutical companies and lay a solid foundation for creating distinctive Zhiheng legal service products. This is not only a positive response to the compliance market of pharmaceutical enterprises, but also a powerful embodiment of Zhiheng's continuous deepening and innovation in the field of professional services, pointing out the direction for providing better and more targeted legal services in this field in the future.
Free communication
free communication site
in the free exchange session, the participants actively discussed the practical pain points of pharmaceutical enterprises to prevent the risk of commercial bribery, and the atmosphere was warm. A number of lawyers combined with their own case questions, the guests answered one by one, for the practical operation to provide specific guidance and suggestions.
Moderator: Li Ci, Secretary-General of the Corporate Compliance Department of the Legal Affairs Center of Zhiheng Company, and Member of the Data Compliance Center of the Qianhai Law Working Committee of Shenzhen Law Association
activity site
group photo
the content of this exchange meeting is detailed and diverse, bringing cutting-edge insights on the compliance of pharmaceutical companies to prevent commercial bribery risks. Participants said that this is a high-quality professional exchange activity, which has both theoretical depth and practical needs. In the future, Zhiheng will adhere to the concept of "unity of knowledge and practice, constant and far-reaching", continue to contribute to the compliance development of the pharmaceutical industry, and help enterprises move forward steadily.